The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-12 2024 | Examining biomarkers in WM cells to predict which patients will relapse
Carmen González Días-Cano, MSc, PhD(c), University of Navarra, Pamplona, Spain, discusses a study examining biomarkers in Waldenström’s macroglobulinemia (WM) cells, from precursor B-cells to plasma cells. These potential biomarkers aim to help identify patients with Waldenström’s macroglobulinemia at high risk of relapse. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
